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Available online 11 May 2016Expanded human T cells from a Japanese healthy male were used to generate integration-free induced pluripo-
tent stem cells (iPSCs) by exogenous expression of four reprogramming factors, OCT3/4, SOX2, cMYC, KLF4, using
Sendai virus vector (SeVdp). The authenticity of established iPSC line, WT-iPSC4, was conﬁrmed by the expres-
sions of stem cell markers and the differentiation capability into three germ layer. WT-iPSC4 may be a useful
cell resource as a normal control for the comparative study using disease-speciﬁc iPSCs.
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consent obtained1. Resource details
Expanded T cells isolated from a 38 year-old Japanese healthy male
were reprogrammed employing Sendai virus vectors (SeVdp) express-
ing four reprogramming factors, OCT3/4, SOX2, cMYC, KLF4. SeVdp is
integration-free vector, and the absence of reprogramming genes
in established iPSC line, WT-iPSC4, was conﬁrmed by PCR analysis. This is an open access article under(Fig. 1A). DNA ﬁngerprint analysis of WT-iPSC4 and expanded T cells
provided the origin of cell source (Fig. 1B). The authenticity of WT-
iPSC4 was conﬁrmed by the followings; (1) the expression of stem cell
markers by immunostaining (Fig. 1C) and RT-PCR (Fig. 1D), (2) the dif-
ferentiation capability into three germ layers using in vitro differentia-
tion through embryoid bodies (EBs) and teratoma formation (Fig. 1E).
In addition, WT-iPSC4 maintains normal karyotype (46, XY) (Fig. 1F),
and Bisulﬁte sequencing revealed that the NANOG promoter region in
WT-iPSC4 was unmethylated (Fig. 1G).2. Materials and methods
2.1. Cell culture
Monocyteswere isolated froma volunteer's peripheral blood sample
using SepMate-50 (STEMCELL technologies, Inc., Canada) and Ficoll-
Paque Plus (GE Healthcare). Consequently, T cell was expanded in TLY
culture kit (LYMPHOTEC, Inc., Japan) for 5–10 days at 37 °C at 5% CO2.
2.2. iPSC generation.
Expanded T cells were reprogrammed by SeVdp as previously
described (Nishimura et al., 2011) and (Itoh et al., 2016). Brieﬂy,
the transfected cells were seeded on feeder cell layer in RPMI1640
with 10% fetal bovine serum and interleukin-2 (PeproTech). After
2 days, the medium was changed to Primate ES cell culture medium
(ReproCELL Inc., Japan) supplemented with basic ﬁbroblast growth
factor (bFGF) (5 ng/ml, R&D Systems), and cultured until colonies
appeared. Established iPSCsweremaintained in human iPS cellmedium
(Itoh et al., 2016). To completely remove SeVdp, siRNA mixture (Itoh
et al., 2016) was added several times into the medium.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Characterization of WT-iPSC4. (A) Conﬁrmation of the absent of SeVdp-related
reprogramming gene by RT-PCR (M: marker, #1: WT-iPSC4, C: control transfected cell
sample). (B) DNA ﬁngerprint analysis by RT-PCR identiﬁed the origin of WT-iPSC4 (M:
marker, Red square: WT-iPSC4 genomic DNA, G: genomic DNA isolated from original T
cells, C: genomic DNA isolated from a different indiviual). The expression of stem cell
markers in WT-iPSC4 was detected by immunostaining (C) and RT-PCR (D) (Red
square: WT-iPSC4 cDNA, E: embryonic stem cell cDNA, M: monocyte cDNA). (E)
Embryoid body and teratoma formation indicated the differentiation capability into
three germ layer, ectoderm (βIII-tubulin and neural epithelium), mesoderm (vimentin
and cartilage) and endoderm (α-fetoprotein and gut epithelium). (F) Karyotype was
normal (46, XY). (G) The NANOG promoter region in WT-iPSC4 was almost completely
unmethylated (White circle: unmethylated CpGs, black circle: methylated CpGs). All the
data suggested the authenticity of WT-iPSC4.
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DNA ﬁngerprint analysis was performed by PCR ampliﬁcation with
speciﬁc primers supplied in (Itoh et al., 2011).2.3. RT-PCR and PCR
RNAwas extracted using an RNeasy Mini Kit (Qiagen), and comple-
mentary DNAwas synthesized using 2 μg RNA by SuperScript III reverse
transcriptase and Oligo-dT primer (Invitrogen) according to the
manufacturer's instructions. PCR reactions were performed withPlatinum PCR SuperMix (Invitrogen). All primer sequences are supplied
in (Itoh et al., 2011) and (Itoh et al., 2016).
2.4. Immunostaining
iPSCs and EBs were ﬁxed with 4% paraformaldehyde(PFA)/PBS and
permeabilized with 0.1% Triton-×100/PBS. After blocking using 10%
goat sera/PBS, samples were incubated for 1 h at room temperature
(RT) or overnight at 4 °C with primary antibodies. After three rinses
with PBS, incubation with appropriate secondary antibodies was per-
formed for 1 h at RT. Nuclei stainingwas performedwith Hoechst33342
(1:1000, Fisher Scientiﬁc)/PBS. Conforcal microscopy (OLYMPUS FV-
300) was used to visualize and capture the immunostained cells with
good resolution. All antibodies are supplied in (Itoh et al., 2016).
2.5. Karyotyping analysis
Karyotyping analysis was offered to Nihon Gene Research Laborato-
ries, Inc., Japan.
2.6. Methylation assay
A total of 1 μg genomic DNA extracted fromWT-iPSC4 was treated
with EZ DNAMethylation-Gold Kit (ZYMO Research, Corp.) for bisulﬁte
reaction. The promoter region of theNANOG genewas ampliﬁed by PCR
using gene-speciﬁc primers (Itoh et al., 2011). PCR product was
subcloned into pCR2.1 vector (Invitrogen), and 10 clones were se-
quenced for deﬁningmethylation status of theNANOG promoter region.
2.7. In vitro differentiation
EBs were made in hiPSCM without bFGF as previously described in
(Itoh et al., 2011) For enhancing spontaneous differentiation, EBs were
attached on gelatin-coated chamber slides and incubated in DMEM
with 10% FBS for 14 days before immunostaining.
2.8. Teratoma formation
Colonies of WT-iPSC4 were collected by 1 mg/ml collagenase IV
(Invitrogen) treatment and subcutaneously injected into nude mice
(CLEA Japan, Inc.)withMatrigel (Corning, Inc.). Palpable tumors typical-
ly appeared 1–2 months after injection. Tumors were collected and
processed for H&E staining according to standard procedures to check
their differentiation capacity into all three germ layers in vivo.
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